Search research articles
Contact Us
Filters
Showing results (61-70 of 221) with videos related to
Page
of 23
Sort By:
Drug and Alcohol Dependence
|
May 15, 2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort
Jake R Morgan, Bruce R Schackman, Zoe M Weinstein, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
February 5, 2020
Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City
Czarina N Behrends, Sarah Gutkind, Regan Deming, et al.
The Journal of Infectious Diseases
|
September 3, 2020
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program
Ashly E Jordan, Charles M Cleland, Bruce R Schackman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 3, 2020
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation
Ashly E Jordan, David C Perlman, Charles M Cleland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2008
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095
Bruce R Schackman, Heather J Ribaudo, Amy Krambrink, et al.
Health Affairs (Project Hope)
|
June 9, 2016
Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians
Yuhua Bao, Yijun Pan, Aryn Taylor, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
February 9, 2002
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS
Bruce R Schackman, Sue J Goldie, Kenneth A Freedberg, et al.
The Journal of Infectious Diseases
|
September 3, 2020
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City
Ashly E Jordan, Charles M Cleland, Katarzyna Wyka, et al.
Substance Use & Misuse
|
December 10, 2021
The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice
Shashi N Kapadia, Judith L Griffin, Justine Waldman, et al.
Journal of Substance Abuse Treatment
|
March 30, 2020
Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future
Ali Jalali, Danielle A Ryan, Kathryn E McCollister, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 221) with videos related to
Sort By:
Page
of 23
Drug and Alcohol Dependence
|
May 15, 2019
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort
Jake R Morgan, Bruce R Schackman, Zoe M Weinstein, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
February 5, 2020
Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City
Czarina N Behrends, Sarah Gutkind, Regan Deming, et al.
The Journal of Infectious Diseases
|
September 3, 2020
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program
Ashly E Jordan, Charles M Cleland, Bruce R Schackman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 3, 2020
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation
Ashly E Jordan, David C Perlman, Charles M Cleland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2008
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095
Bruce R Schackman, Heather J Ribaudo, Amy Krambrink, et al.
Health Affairs (Project Hope)
|
June 9, 2016
Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians
Yuhua Bao, Yijun Pan, Aryn Taylor, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
February 9, 2002
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS
Bruce R Schackman, Sue J Goldie, Kenneth A Freedberg, et al.
The Journal of Infectious Diseases
|
September 3, 2020
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City
Ashly E Jordan, Charles M Cleland, Katarzyna Wyka, et al.
Substance Use & Misuse
|
December 10, 2021
The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice
Shashi N Kapadia, Judith L Griffin, Justine Waldman, et al.
Journal of Substance Abuse Treatment
|
March 30, 2020
Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future
Ali Jalali, Danielle A Ryan, Kathryn E McCollister, et al.
Page
of 23